Skip to main content
SpringerLink
Log in
Book cover

Pathologie pp 161–165Cite as

Mammakarzinome mit Keimbahnmutationen

  • Chapter
  • First Online:

  • 5710 Accesses

Part of the book series: Pathologie ((PATHOL))

Zusammenfassung

Das Kapitel behandelt die Besonderheiten der Mammakarzinome, die im Zusammenhang mit den häufigen und seltenen Keimbahnmutationen familiär gehäuft auftreten. Insbesondere wird auf die Brustkrebsgene BRCA1 und BRCA2 eingegangen.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Literatur

  1. Agnarsson BA, Jonasson JG, Bjornsdottir IB et al (1998) Inherited BRCA2 mutation associated with high grade breast cancer. Breast Cancer Res Treat 47:121–127

    Article  PubMed  CAS  Google Scholar 

  2. Armes JE, Egan AJ, Southey MC et al (1998) The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: a population-based study. Cancer 83:2335–2345

    Article  PubMed  CAS  Google Scholar 

  3. Arun B, Vogel KJ, Lopez A et al (2009) High prevalence of preinvasive lesions adjacent to BRCA1/2-associated breast cancers. Cancer Prev Res (Phila) 2:122–127

    Article  CAS  Google Scholar 

  4. Atchley DP, Albarracin CT, Lopez A et al (2008) Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer. J Clin Oncol 26:4282–4288

    Article  PubMed  Google Scholar 

  5. Bässler R (1997) Pathologie prognostischer Kriterien. In: Remmele W (ed) Pathologie – Weibliches Genitale. Mamma, Pathologie der Schwangerschaft, der Plazenta und des Neugeborenen, Infektionskrankheiten des Fetus und des Neugeborenen, Tumoren des Kindesalters, Endokrine Organe. vol. 4. Springer, Berlin Heidelberg New York, pp 240–253

    Google Scholar 

  6. Bloom HJ, Richardson WW (1957) Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11:359–377

    Article  PubMed  CAS  Google Scholar 

  7. Bordeleau L, Panchal S, Goodwin P (2010) Prognosis of BRCA-associated breast cancer: a summary of evidence. Breast Cancer Res Treat 119:13–24

    Article  PubMed  CAS  Google Scholar 

  8. Comen EA, Robson M (2010) Inhibition of poly(ADP)-ribose polymerase as a therapeutic strategy for breast cancer. Oncology (Williston Park) 24:55–62

    Google Scholar 

  9. Contesso G, Mouriesse H, Friedman S et al (1987) The importance of histologic grade in long-term prognosis of breast cancer: a study of 1,010 patients, uniformly treated at the Institut Gustave-Roussy. J Clin Oncol 5:1378–1386

    PubMed  CAS  Google Scholar 

  10. Farges O, Fuks D, Le Treut YP et al (2011) AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: By the AFC-IHCC-2009 study group. Cancer 117:2170–2177

    Article  PubMed  Google Scholar 

  11. Farshid G, Balleine RL, Cummings M et al (2006) Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing. Am J Surg Pathol 30:1357–1366

    Article  PubMed  Google Scholar 

  12. Gadzicki D, Schubert A, Fischer C et al (2009) Histopathological criteria and selection algorithms for BRCA1 genetic testing. Cancer Genet Cytogenet 189:105–111

    Article  PubMed  CAS  Google Scholar 

  13. Galea MH, Blamey RW, Elston CE et al (1992) The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat 22:207–219

    Article  PubMed  CAS  Google Scholar 

  14. Gonzalez KD, Noltner KA, Buzin CH et al (2009) Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations. J Clin Oncol 27:1250–1256

    Article  PubMed  CAS  Google Scholar 

  15. Gonzalez MA, Pinder SE (2011) Invasive carcinoma: other histologic, prognostic factors, prognostic indices, and application of prognostic information for patient management. In: O'Malley FP, Pinder SE, Mulligan AM (eds) Breast pathology. Elsevier, Philadelphia, pp 272–278

    Chapter  Google Scholar 

  16. Gustafson S, Zbuk KM, Scacheri C et al (2007) Cowden syndrome. Semin Oncol 34:428–434

    Article  PubMed  CAS  Google Scholar 

  17. Habeck M (1999) New hepatitis virus discovered. Mol Med Today 5:462

    Article  PubMed  CAS  Google Scholar 

  18. Honrado E, Benitez J, Palacios J (2005) The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications. Mod Pathol 18:1305–1320

    Article  PubMed  CAS  Google Scholar 

  19. Honrado E, Osorio A, Palacios J et al (2006) Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations. Oncogene 25:5837–5845

    Article  PubMed  CAS  Google Scholar 

  20. Kuhn W, Schmalfeldt B, Reuning U et al (1999) Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc. Br J Cancer 79:1746–1751

    Article  PubMed  CAS  Google Scholar 

  21. Lakhani SR, Jacquemier J, Sloane JP et al (1998) Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 90:1138–1145

    Article  PubMed  CAS  Google Scholar 

  22. Le Doussal V, Tubiana-Hulin M, Friedman S et al (1989) Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas. Cancer 64:1914–1921

    Article  PubMed  Google Scholar 

  23. Marcus JN, Watson P, Page DL et al (1996) Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer 77:697–709

    Article  PubMed  CAS  Google Scholar 

  24. Marcus JN, Watson P, Page DL et al (1997) BRCA2 hereditary breast cancer pathophenotype. Breast Cancer Res Treat 44:275–277

    Article  PubMed  CAS  Google Scholar 

  25. Narod SA (2010) BRCA mutations in the management of breast cancer: the state of the art. Nat Rev Clin Oncol 7:702–707

    Article  PubMed  CAS  Google Scholar 

  26. Nevanlinna H, Bartek J (2006) The CHEK2 gene and inherited breast cancer susceptibility. Oncogene 25:5912–5919

    Article  PubMed  CAS  Google Scholar 

  27. Osin PP, Lakhani SR (1999) The pathology of familial breast cancer: Immunohistochemistry and molecular analysis. Breast Cancer Res 1:36–40

    Article  PubMed  CAS  Google Scholar 

  28. Pinder SE, Ellis IO, Galea M et al (1994) Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up. Histopathology 24:41–47

    Article  PubMed  CAS  Google Scholar 

  29. Prokopcova J, Kleibl Z, Banwell CM et al (2007) The role of ATM in breast cancer development. Breast Cancer Res Treat 104:121–128

    Article  PubMed  CAS  Google Scholar 

  30. Quenneville LA, Phillips KA, Ozcelik H et al (2002) HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry. Cancer 95:2068–2075

    Article  PubMed  CAS  Google Scholar 

  31. Rakha EA, El-Sayed ME, Lee AH et al (2008) Prognostic significance of Nottingham histologic grade in invasive breast carcinoma. J Clin Oncol 26:3153–3158

    Article  PubMed  Google Scholar 

  32. Rakha EA, El-Sayed ME, Menon S et al (2008) Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast. Breast Cancer Res Treat 111:121–127

    Article  PubMed  Google Scholar 

  33. Rebbeck TR, Lynch HT, Neuhausen SL et al (2002) Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346:1616–1622

    Article  PubMed  Google Scholar 

  34. Schrader KA, Masciari S, Boyd N et al (2008) Hereditary diffuse gastric cancer: association with lobular breast cancer. Fam Cancer 7:73–82

    Article  PubMed  Google Scholar 

  35. Schumacher M, Schmoor C, Sauerbrei W et al (1993) The prognostic effect of histological tumor grade in node-negative breast cancer patients. Breast Cancer Res Treat 25:235–245

    Article  PubMed  CAS  Google Scholar 

  36. Shore RE, Hempelmann LH, Kowaluk E et al (1977) Breast neoplasms in women treated with x-rays for acute postpartum mastitis. J Natl Cancer Inst 59:813–822

    PubMed  CAS  Google Scholar 

  37. Turner N, Tutt A, Ashworth A (2004) Hallmarks of 'BRCAness' in sporadic cancers. Nat Rev Cancer 4:814–819

    Article  PubMed  CAS  Google Scholar 

  38. Turner NC, Reis-Filho JS (2006) Basal-like breast cancer and the BRCA1 phenotype. Oncogene 25:5846–5853

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Author notes

  1. Werner Böcker Prof. em. Dr. med.

    Present address: Referenz- und Konsultationszentrum für Gynäko- und Mammapathologie, Fangdieckstr. 75a, 22547, Hamburg, Deutschland

Authors and Affiliations

  1. Gerhard Domagk Institut für Pathologie der Universität Münster, Münster, Deutschland

    Werner Böcker Prof. em. Dr. med.

Authors
  1. Werner Böcker Prof. em. Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Werner Böcker Prof. em. Dr. med. .

Editor information

Editors and Affiliations

  1. Institut für Pathologie, Konsultationszentrum für Pankreas- und, TU München, Ismaninger Str. 22, München, 81675, Germany

    Günter Klöppel

  2. Inst. Pathologie, Medizinische Hochschule Hannover (MHH), Carl-Neuberg-Str. 1, Hannover, 30623, Germany

    Hans Kreipe

  3. Kliniken der Landeshauptstadt, Institut für Pathologie, Ludwig-Erhard-Straße 100, Wiesbaden, 65199, Germany

    Wolfgang Remmele

  4. Charite - Universitätsmedizin Berlin, Campus Charité Mitte, Institut für Pathologie, Charitéplatz 1, Berlin, 10117, Berlin, Germany

    Manfred Dietel

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Böcker, W. (2013). Mammakarzinome mit Keimbahnmutationen. In: Klöppel, G., Kreipe, H., Remmele, W., Dietel, M. (eds) Pathologie. Pathologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-04564-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-04564-6_8

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-04563-9

  • Online ISBN: 978-3-642-04564-6

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation